Blood Collection Market Outlook 2025-2033: Size, Share, and Forecast Driven by Affordable Diagnostic Tests

Market Overview

The global blood collection market, valued at USD 7.26 billion in 2024, is expected to reach USD 10.36 billion by 2033, growing at a 4.03% CAGR. This expansion is driven by rising healthcare demand, increasing prevalence of chronic diseases, innovations in minimally invasive tools, and robust funding in diagnostics—making blood collection more precise, accessible, and patient-friendly.

Study Assumption Years

• Base Year: 2024
• Historical Year: 2019–2024
• Forecast Year: 2025–2033

Blood Collection Market Key Takeaways

• North America leads, holding ~41.2% market share in 2024.
• The blood collection market size was USD 7.26 B in 2024 and is forecast to reach USD 10.36 B by 2033 at a 4.03% CAGR.
• Product segmentation: Needles & syringes, blood collection tubes (serum‑separating, EDTA, heparin, plasma‑separating), blood bags, and others.
• By application: Diagnostics (≈66.7%), driven by early and precise testing; treatment also contributes.
• End use: Hospitals dominate (~37.2%), followed by diagnostic centres, blood banks, and others.
• Key market drivers include chronic diseases, aging populations, rapid surgical growth, and technological innovation.

Market Growth Factors

Affordable Diagnostics Transforming Healthcare

One of the biggest reasons the blood collection industry is advancing is the rising need for affordable and precise diagnostic tests. Healthcare providers and patients alike are demanding tests that are both cost-effective and reliable, especially for early detection of chronic illnesses such as diabetes, cardiovascular diseases, and cancer. Blood collection serves as the backbone of these diagnostics, making it a vital step in healthcare delivery. With the push toward affordable healthcare in both developed and emerging economies, the reliance on efficient blood collection systems is higher than ever. This demand directly fuels innovations in collection tubes, needles, and devices that ensure accuracy while keeping costs low. As hospitals and diagnostic labs expand across rural and urban regions, the scalability of these affordable tests becomes critical, pushing the industry further. Buyers of this report will gain insights into how affordability is shaping future strategies of key players.

Chronic Diseases Fuelling Testing Needs

The alarming rise in chronic and lifestyle-related diseases has created continuous demand for blood-based diagnostics. Conditions like diabetes, obesity, cardiovascular disorders, and hypertension are increasing due to changing diets, sedentary lifestyles, and aging populations. All these conditions require frequent blood testing for monitoring and management. For instance, diabetic patients often undergo regular blood glucose checks, which demand accurate and efficient collection systems. This ongoing requirement translates into consistent demand for collection products across the globe. Moreover, governments and private healthcare providers are investing heavily in early diagnosis programs to reduce long-term healthcare costs. The growing disease burden not only highlights the importance of collection devices but also encourages innovation to make the process safer, quicker, and less invasive. This report offers a deep dive into these trends and explains why the increasing prevalence of such diseases is directly linked to industry expansion.

Blood Donation Campaigns Driving Growth

Donation programs and awareness drives worldwide are significantly boosting adoption of modern collection solutions. With rising global health crises, including accidents, surgeries, and chronic illnesses, blood donation has become a life-saving activity. Governments, NGOs, and healthcare organizations are running large-scale initiatives to encourage voluntary donation, which has led to higher collection volumes. For example, countries with rising road accident rates or cancer treatments requiring transfusions depend heavily on safe and efficient collection systems. Enhanced awareness also reduces the stigma or fear associated with donation, leading to increased participation. As a result, hospitals and blood banks are investing in advanced bags, collection needles, and storage solutions to meet the demand. Understanding these dynamics is crucial for businesses aiming to tap into this growing opportunity. This report explains how donation initiatives directly support the growth of collection technologies across different regions.

Explore the Blood Collection Market — Get Your Free Sample Now https://www.imarcgroup.com/blood-collection-market/requestsample

Market Segmentation

• By Product:
  • Needles and Syringes
  • Blood Collection Tubes
    • Serum-separating
    • EDTA
    • Heparin
    • Plasma-separating
  • Blood Bags
  • Others
• By Application:
  • Diagnostics
  • Treatment
• By End Use:
  • Hospitals
  • Diagnostics Centers
  • Blood Banks
  • Others
• Breakup By Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Regional Insights

North America is leading the way with a significant 41.2% market share, primarily driven by the U.S. The region benefits from a robust healthcare infrastructure, a high prevalence of chronic diseases like diabetes, cardiovascular issues, and cancer, along with a strong embrace of automated diagnostics, all of which fuel growth. Additionally, government initiatives and a culture that encourages blood donation further solidify North America's position at the forefront.

Recent Developments & News

Recent advancements include the 2024 launch of the ICHOR line by Husky Technologies and Kriya Medical in India, which has the capacity to produce an impressive 250 million blood tubes each year. Meanwhile, BD has expanded its partnership with Babson Diagnostics to facilitate home-based blood collection, enhancing the shift towards decentralized, patient-focused diagnostics. On a global scale, capillary point-of-care tools that prioritize safety are becoming increasingly popular, such as Terumo’s devices in the Asia-Pacific region and BD’s MiniDraw in the U.S.

Key Players

• Abbott Laboratories
• Becton Dickinson and Company
• FL MEDICAL s.r.l.
• Greiner AG
• Haemonetics Corporation
• McKesson Corporation
• Medtronic plc
• Nipro Corporation
• Qiagen N.V.
• Quest Diagnostics
• Sarstedt AG & Co. KG
• Terumo Corporation

Schedule a Free Consultation with Our Experts- https://www.imarcgroup.com/request?type=report&id=4975&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us: 

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (+1-201971-6302)